Aristolochic acid as a scaffold for antitumor drug development.

被引：0
|
作者：
Hashimoto, Keiji [1 ]
Chennamshetti, Rajesh [1 ]
Bonala, Radha [1 ]
Johnson, Francis [1 ]
Grollman, Arthur P. [1 ]
Sidorenko, Viktoriya S. [1 ]
机构：
[1] SUNY Stony Brook, Stony Brook, NY USA
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5480
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Mycotoxic and aristolochic acid theories of the development of endemic nephropathy
    Peraica, Maja
    Domijan, Ana-Marija
    Saric, Marko
    ARHIV ZA HIGIJENU RADA I TOKSIKOLOGIJU-ARCHIVES OF INDUSTRIAL HYGIENE AND TOXICOLOGY, 2008, 59 (01): : 59 - 65
  • [22] The importance of indole and azaindole scaffold in the development of antitumor agents
    Han, Yu
    Dong, Wei
    Guo, Qunqun
    Li, Xiufen
    Huang, Longjiang
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 203
  • [23] Computer assisted drug development (CADD): An emerging technology for accelerating drug development.
    Gomeni, R
    Bani, M
    D'Angeli, C
    Corsi, M
    Bye, A
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P3 - P3
  • [24] Learning acid innovation in economic development.
    Metcalfe, JS
    R & D MANAGEMENT, 2000, 30 (04) : 371 - 372
  • [25] Short-term toxicity of aristolochic acid, aristolochic acid-I and aristolochic acid-II in rats
    Yeh, Yen-Hung
    Lee, Ya-Ting
    Hsieh, Hung-Sheng
    Hwang, Deng-Fwu
    FOOD AND CHEMICAL TOXICOLOGY, 2008, 46 (03) : 1157 - 1163
  • [26] Indoles - A promising scaffold for drug development
    Sravanthi, T. V.
    Manju, S. L.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 91 : 1 - 10
  • [27] The Potential of the Cyclotide Scaffold for Drug Development
    Camarero, Julio A.
    Campbell, Maria Jose
    BIOMEDICINES, 2019, 7 (02)
  • [28] Heterogeneous acid alkylation catalyst development.
    Kocal, JA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U169 - U169
  • [29] 2,7-naphthyridinone-based MET kinase inhibitors: A promising novel scaffold for antitumor drug development
    Zhuo, Lin-Sheng
    Xu, Hong-Chuang
    Wang, Ming-Shu
    Zhao, Xing-E
    Ming, Zhi-Hui
    Zhu, Xiao-Lei
    Huang, Wei
    Yang, Guang-Fu
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 178 : 705 - 714
  • [30] The revised European guidelines for anticancer drug development.
    Therasse, P
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9178S - 9178S
12345